Cerebrospinal GFAP Levels in Double-Seronegative NMOSD Indicate Different Pathology - Neurology Live

7/19/2022 12:00:00 AM2 years 9 months ago
by Marco Meglio
by Marco Meglio
Using rigorous cell-based assays, cerebrospinal fluid GFAP levels were significantly lower in double-seronegative NMOSD than AQP4-positive NMOSD but did not differ between those with MOGAD or other neurological diseases.
In a recent analysis comparing the differences of double seronegative neuromyelitis optica spectrum disorder (DN-NMOSD) and aquaporin-4 (AQP4)-positive NMOSD, findings showed that those with DN-NMOSD… [+4601 chars]
full article...